Skip to main content

Table 4 Univariate and multivariate analyses for lung cancer patients on overall survival in the GSE30219

From: CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

Variable Univariate analysis Multivariate analysis
HR (95% CI) p-value HR (95% CI) p-value
Age (≤ 55 vs >5 5 years) 1.039 (1.025–1.054) 0.000 1.041 (1.026–1.056) 0.000
Gender
 Female vs male 0.573 (0.360–0.910) 0.018 0.670 (0.419–1.071) 0.094
T stage
 T1 vs T2 vs T3 vs T4 1.625 (1.415-1.866) 0.000 1.311 (1.082–1.590) 0.006
N stage
 N0 vs N1 vs N2 vs N4 1.730 (1.472–2.034) 0.000 1.371 (1.097–1.715) 0.006
M stage
 M0 vs M1 2.718 (1.114–6.631) 0.028 2.432 (0.987–5.997) 0.054
CLEC3B expression
 High vs low 0.565 (0.423–0.753) 0.000 0.789 (0.577–1.077) 0.136
  1. CI, confidence interval; HR, hazard ratio